Caudill Cortney

Caudill Cortney is listed in filings as SVP at Halozyme Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 10, 2026, including sale activity. Recent filings connect the profile to Halozyme Therapeutics, Inc. (HALO). The current snapshot covers public activity from Oct 6, 2025 to Mar 10, 2026. Reported amounts are shown as $599.1K to $1.2M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.